Supriya Lifescience Limited (SUPRIYA) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Supriya Lifescience Limited stock ₹414, price ₹622, that is 33.5% below the price, quality 57 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Supriya Lifescience Limited
SUPRIYA · NSEExpensive (fair value 34% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
59‑month range ₹174.89 – ₹1,051 · fair‑value band ₹180.65 – ₹702.42 · the ₹622.30 price screens above the ₹413.92 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Every Wednesday you see whether Supriya Lifescience is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.
Show moreShow less
The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products.
In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit.
Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine.
Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
Stock analysis
Supriya Lifescience Limited (SUPRIYA) currently trades at ₹622.30, while our model-based Fair Value estimate is ₹413.92, 34% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹709.55 per share, and 3 of the 26 models we run sit above the ₹622.30 price.
Bear case: the Asset-Based group reads lowest at ₹46.34, and 23 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹180.65 (bear) to ₹702.42 (bull), the price of ₹622.30 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Supriya Lifescience Limited reported revenue of ₹8.3B in FY2026 versus ₹5.2B in FY2022, a compound +12.4%/yr. Reported net income was ₹2.1B in FY2026, compounding +8.3%/yr from FY2022.
Key figures
Market cap ₹50.1B (≈ $532M) Small · P/E ratio 28.3 · P/S ratio 5.74 · EPS (TTM) ₹22.01 · Dividend yield 0.2% · Net margin 22.7% · Return on equity 19.1% · Return on assets (EBIT) 20.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 80 out of 100 (medium confidence).
What moves the price
The share trades about 41% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at −34%, SUPRIYA screens richer than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Compare Supriya Lifescience Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 849 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Net margin by industry
- P/B ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $955.47 | $1,275 | +33% | vs SUPRIYA |
| Vertex Pharmaceuticals Incorporated VRTX | $538.60 | $592.46 | +10% | vs SUPRIYA |
| Samsung Biologics Co 207940 | 1,423,000 KRW | 1,552,100 KRW | +9% | vs SUPRIYA |
| argenx SE ARGX | $960.04 | $908.40 | −5% | vs SUPRIYA |
| CSL Limited CSL | A$202.52 | A$185.51 | −8% | vs SUPRIYA |
| BeOne Medicines AG 6160 | HK$249.40 | HK$152.92 | −39% | vs SUPRIYA |
| Moderna, Inc MRNA | $223.37 | $135.64 | −39% | vs SUPRIYA |
| Revolution Medicines, Inc RVMD | $172.29 | $88.78 | −48% | vs SUPRIYA |
| Celltrion, Inc 068270 | 214,500 KRW | 74,945 KRW | −65% | vs SUPRIYA |
| Royalty Pharma plc RPRX | $69.31 | $19.01 | −73% | vs SUPRIYA |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Supriya Lifescience Limited (SUPRIYA) overvalued or undervalued?
What is the fair value of SUPRIYA?
What is the quality score of SUPRIYA?
What is the price target for Supriya Lifescience Limited (SUPRIYA)?
What is the Supriya Lifescience Limited stock forecast for 2026?
What is the revenue of Supriya Lifescience Limited (SUPRIYA)?
Does Supriya Lifescience Limited pay a dividend?
How much is the dividend of Supriya Lifescience Limited (SUPRIYA) and when is the ex-dividend date?
What growth is priced into Supriya Lifescience Limited (SUPRIYA)?
What discount rate (WACC) does the fair value of SUPRIYA use?
What is a reverse DCF?
How much growth has Supriya Lifescience Limited (SUPRIYA) delivered so far?
How fast is the sector of Supriya Lifescience Limited (SUPRIYA) growing?
What is the free cash flow yield of Supriya Lifescience Limited (SUPRIYA)?
What is the intrinsic value of Supriya Lifescience Limited (SUPRIYA)?
Is Supriya Lifescience Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of SUPRIYA?
How much is Supriya Lifescience Limited worth?
What do the bullish and bearish scenarios say about SUPRIYA?
What is the P/E ratio of SUPRIYA?
How solid is the balance sheet of Supriya Lifescience Limited (SUPRIYA)?
How far is SUPRIYA from its 52-week high?
Which stocks are comparable to Supriya Lifescience Limited?
Is Supriya Lifescience Limited stock attractive at the current price?
How is the fair value of SUPRIYA calculated?
Is it still worth investing in stocks now?
What is the share price of Supriya Lifescience Limited (SUPRIYA)?
What should I pay attention to with Supriya Lifescience Limited right now?
Key figures of Supriya Lifescience Limited
How large is the market capitalisation of Supriya Lifescience Limited (SUPRIYA)?
What is the P/S ratio of Supriya Lifescience Limited (SUPRIYA)?
What are the earnings per share of Supriya Lifescience Limited (SUPRIYA)?
What is the dividend yield of Supriya Lifescience Limited (SUPRIYA)?
What is the net margin of Supriya Lifescience Limited (SUPRIYA)?
What is the return on equity of Supriya Lifescience Limited (SUPRIYA)?
What is the EBIT return on assets of Supriya Lifescience Limited (SUPRIYA)?
What is the operating margin of Supriya Lifescience Limited (SUPRIYA)?
How fast is revenue growing at Supriya Lifescience Limited (SUPRIYA)?
How fast are earnings growing at Supriya Lifescience Limited (SUPRIYA)?
How much net cash does Supriya Lifescience Limited (SUPRIYA) hold?
Watch Supriya Lifescience Limited in the live analysis
One click puts Supriya Lifescience Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.